Recent studies show that the rate of cocaine use by pregnant women in the United States is much higher than realized hitherto, and an increasing number of infants are being born to cocaine-using mothers. In an ongoing research project to study the effects of cocaine on pregnancy outcome, we studied 70 infants born to cocaine-using women. These infants were matched to a drug-free comparison group selected from the population of the same hospital: children of pregnant women of a similar racial and socioeconomic distribution, but with no history or evidence of licit or illicit drug use during pregnancy. Cocaine-exposed infants had lower birth weight, shorter gestation, and a smaller head circumference than control infants. Cocaine-exposed infants also had neurobehavioral abnormalities at initial evaluation and a higher rate of perinatal complications. Toxicological evaluation of urines of neonates born to cocaine-using women showed that benzoylecgonine, a primary metabolite of cocaine, persisted in the urines for as long as 120 h after delivery. We discuss the role of the immature fetal and neonatal system in the clinical and toxicological outcome of the infant, and emphasize that further long-term studies of this will be needed. women showed that women 18-to 34-years-old constituted 15% of regular cocaine users (5). These data underscore the growing number of women in the prime child-bearing years who are using and abusing cocaine, and they explain the increasing numbers of cocaine-using pregnant women being seen around the country. In a recent survey of 36 hospitals across the United States (6), 11% of all women delivering in those hospitals had used an illicit substance at some time during their pregnancy. This survey excluded licit drugs such as alcohol and over-the-counter preparations and confirmed by maternal history or positive urine toxicology that cocaine was the most common illicit substance used by these women. Interestingly, the high rate of use of illicit substances, especially cocaine, cut across all socioeconomic lines, such that the incidence within hospitals varied not according to demo-
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As the negative impact of substance abuse, especially abuse of cocaine, on pregnancy and the newborn has become more greatly appreciated (1-3), toxicological evaluation of the mother's urine during pregnancy is being For evaluation of outcome of the cocaine-exposed infants, a drug-free comparison group (n = 70) was selected from the population of the Prentice Ambulatory Care Clinic.
Comparison-group mothers had no history or evidence of licit or illicit drug use and were selected for the control group on the basis of social, demographic, and environmental backgrounds as well as comparability of cigarette use during pregnancy (Table 1) . Urines for all cocaine-using women were negative for other substances except alcohol and marijuana as noted in Table 1 . Obstetric management of pregnancy was similar for the two groups of women and has been described in previous publications (7, 8) . The reproductive histories of all women were reviewed and labor and delivery data recorded at the time of delivery. All neonates were examined at birth. Trained examiners who were not informed of the infants' prenatal history administered The Neonatal Behavioral Assessment Scale (9) when the infants delivered at term (38-42 weeks of gestation) were 12-to 72-h old and again when they were one month old. We used appropriate statistical measures for parametric and nonparametric data to analyze differences between the cocaine-exposed and drug-free groups. Immediately after birth, urine specimens were collected from all neonates. If the infant had a positive urine test result for cocaine or for benzoylecgonine, the primary metabolite of cocaine, we collected urine specimens every 8 h for as long as five to six days after delivery. Twenty neonates had a complete series of urine samples collected. All the neonatal urine samples were stored at Northwestern Memorial Hospital until transport to the toxicology laboratory on the next working day. Samples were then stored at -20 #{176}C until the analysis was performed. All urine samples were screened for benzoylecgonine by using Syva's EMIT d.a.u. kits according to the manufacturer's recommendations.
For confirmatory assay for benzoylecognine-positive samples, we used GC/MS. When the second test method did not indicate the presence of cocaine metabolites, the sample was classified as drug-negative. We quantitatively analyzed samples positive for cocaine metabolites by GC/MS, which could detect as little as 20 ng of benzoylecgonine per milliliter of urine. The GC/MS technique involves bonded-phase extraction.
All metabolites were derivatized to facilitate analysis by yielding a more volatile molecule. Each urine sample was analyzed for cocaine and benzoylecgonine, with calibration based on standards received from the National Institute on Drug Abuse.
Results
As is the case for other substance-abusing populations, the cocaine-addicted women had a high incidence of infectious-disease complications, especially hepatitis (24%) and venereal disease (10.5%). They also had more complications of labor and delivery than the drug-free women ( Table 2 ). The use of alcohol and (or) marijuana did not affect outcome with regard to labor and delivery or fetal complications.
All the infants were single births, and there was a similar distribution of infants by sex in each group. Moreover, a similar number of infants in each group had Apgar scores <7 at 1 and 5 mm. However, the cocaine-exposed group of infants had meconium staining more frequently than the control group of infants (Table 2 ). There was also an increased incidence of premature labor among the cocaine-complicated pregnancies, so that mean gestational age was reduced for the cocaine-exposed infants. Birth weights, crown-rump lengths, and head circumferences were significantly different (Table 3) between infants in the two groups who were delivered at term ( 38 weeks of gestation).
Perinatal complications are shown in Table 4 , the most No infant in the cocaine-exposed group required pharmacological therapy for symptoms of abstinence; however, eight of them had malformations of the genitourinary tract: two with "prune-belly syndrome," one with female pseudohermaphroditism, two with a first-degree hypospadias and undescended testes, and three with hydroureter/hydronephrosis. Two infants in the cocaine-exposed group suffered a perinatal cerebral infarction related to their mother's cocaine use in the 48 to 72 h before delivery, and three cocaine-exposed infants presented with ileal atresia at 24 h.
Cluster analysis (10) of results of the Neonatal Behavioral Assessment Scale revealed that cocaine-exposed newborn infants exhibited poor motor, orientation, and stateregulation behaviors. Although these had improved considerably by one month postpartum, orientation and stateregulation abilities were still substantially poorer than was true for the drug-free newborns (11).
Toxicological evaluation of neonatal urines showed that benzoylecgonine persisted in the urines of the recently exposed neonates 48-120 h (mean 80 h) after delivery.
DIscussIon
There is no question that cocaine use by pregnant women has become a major concern of health workers in the United States. However, little information exists as to the exact effects that cocaine has upon pregnancy and the developing fetus. Our preliminary study of 23 cocaineusing women and their offspring (1) suggested that cocaine would have significant effects on pregnancy outcome. These initial impressions have been borne out in the present study.
The incidence of complications of labor and delivery in the drug-free group of women in the present study were similar to that of the general population.
However, the cocaine-using women had a higher rate of complications of labor and delivery than the control women. Cocaine acts peripherally to inhibit nerve conduction and prevent norepinephrine re-uptake at the nerve terminals, producing increased concentrations of norepmnephrine in blood with subsequent vasoconstriction and tachycardia and a concomitant abrupt increase in blood pressure (12). Placental vasoconstriction also occurs (13), decreasing blood flow to the fetus, and increased concentrations of norepinephrine are associated with an increase in uterine contractility in human beings (14). The increased incidence of preterm labor and abruptio placentae is consistent with these pharmacological actions of cocaine.
Maternal problems at delivery are reflected in the high rate of fetal distress noted in the cocaine-exposed infants, as manifested by fetal monitor abnormalities and fetal meconium staining. The pennatal cerebral infarction noted in two of these infants is a severe example of the morbidity associated with intrauterine exposure to cocaine (2) and is similar to intracerebral insults reported in adults who use cocaine. The occurrence of genitourinary malformations of the cocaine-exposed infants (3) is consistent with results of animal studies; e.g., incidence of crypthrchidism and hydronephrosis was increased in mice (15). However, larger numbers of cocaine-exposed infants must be studied before we draw conclusions regarding the association of congenital malformations with cocaine use. The impaired intrauterine growth noted in infants exposed to cocaine is consistent with the vasoconstrictive action of cocaine. Infant responses to the Neonatal Behavioral Assessment Scale indicated that newborn cocaine-exposed infants as a group experienced deficiencies in both their ability to move adaptively through the various states of arousal in response to the demands of testing and in their ability to attend to and actively engage auditory and/or visual stunuli. Most of the cocaine-exposed infants could be classified as "fragile" infants, i.e., easily overloaded by environmental stimuli. The newborn cocaine-exposed infants had very few self-protective mechanisms for avoiding overstimulation and required considerable assistance from caretakers to maintain control of their hyperexcitable nervous systems. Cocaine and its metabolites reportedly persist in the urine of adults for as long as 27 h after intranasal use (16). The persistence of benzoylecgonine in the neonates' urines for 120 h after delivery may be evidence for slower metabolism of cocaine by the neonate, may represent slower renal clearance, or may be due to slow elimination from a deep compartment.
With the increasing use of cocaine by pregnant women, evaluation of risk factors for the infant will have increasing importance in providing for maternal-child health. An important mediating factor in the response of the fetus or neonate to drug exposure is the individual's ability to metabolize and tolerate the illicit substance. This ability is determined through various factors, including genetic and physiological ones. The immaturity of the fetal and neonatal system may play an important role in the clinical outcome of the infant. Further studies are needed to elucidate this role fully.
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